Skip to main content

Hemophilia A

Study of Biostate® in Children With Hemophilia A
NCT01229007 | PHASE 3 | INTERVENTIONAL

The objective of this study is to assess the efficacy and safety of a Von Willebrand Factor/Factor VIII (VWF/FVIII), Biostate, and to investigate the pharmacokinetics of Biostate in children with haemophilia A.

Trial Information
8 Sites
35 Participants
Recruiting
18 Years to 12 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Study site
Gomel,Belarus,246040
Study site
Minsk,Belarus,223040
Study Site
Tbilisi,Georgia,0179
Study Site
Guatemala,Guatemala,01010
Study Site
Beirut,Lebanon
Study site
Monterrey,Mexico,64000
Study Site
Dnipropetrovsk,Ukraine
Study Site
Lviv,Ukraine

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov